Diffusion Pharmaceuticals Inc. - FORM 10-K - EX-99.1 - IN ACCORDANCE WITH THE TEMPORARY HARDSHIP EXEMPTION PROVIDED BY RULE 201 OF REGULATION S-T, THE DATE BY WHICH THE INTERACTIVE DATA FILE IS REQUIRED TO BE SUBMITTED HAS BEEN EXTENDED BY SIX BUSINESS DAYS. - April 16, 2013

Attached files

file filename
10-K - ANNUAL REPORT - Diffusion Pharmaceuticals Inc.stratus_10k-123112.htm
EX-31.1 - CERTIFICATION - Diffusion Pharmaceuticals Inc.stratus_10k-ex3101.htm
EX-10.15 - EMPLOYMENT AGREEMENT - Diffusion Pharmaceuticals Inc.stratus_10k-ex1015.htm
EX-32.2 - CERTIFICATION - Diffusion Pharmaceuticals Inc.stratus_10k-ex3202.htm
EX-32.1 - CERTIFICATION - Diffusion Pharmaceuticals Inc.stratus_10k-ex3201.htm
EX-31.2 - CERTIFICATION - Diffusion Pharmaceuticals Inc.stratus_10k-ex3102.htm
EX-99.1 7 stratus_10k-ex9901.htm IN ACCORDANCE WITH THE TEMPORARY HARDSHIP EXEMPTION PROVIDED BY RULE 201 OF REGULATION S-T, THE DATE BY WHICH THE INTERACTIVE DATA FILE IS REQUIRED TO BE SUBMITTED HAS BEEN EXTENDED BY SIX BUSINESS DAYS.

Exhibit 99.1

 

 

IN ACCORDANCE WITH THE TEMPORARY HARDSHIP EXEMPTION PROVIDED BY RULE 201 OF REGULATION S-T, THE DATE BY WHICH THE INTERACTIVE DATA FILE IS REQUIRED TO BE SUBMITTED HAS BEEN EXTENDED BY SIX BUSINESS DAYS.

Diffusion Pharmaceuticals Inc. Reports